Covishield

No extra risk of blood clot after second shot of AstraZeneca’s COVID-19 vaccine, says Lancet study

TTS (thrombosis with thrombocytopenia syndrome) is an extremely rare syndrome occurred when a person has blood clots along with low blood platelets.

A new study claims that no antibodies were found against Delta in 16% samples after both doses of Covishield

Dr. T Jacob John of Christian Medical College, Vellore has said “not observed is not equivalent to not present.”

Swtizerland, along with 7 EU countries, add Covishield on their list of approved vaccines

The announcement comes just a day after India had urged the EU to exempt those vaccinated with Covishield and Covaxin from travel curbs within member states.

DCGI gives approval to Cipla to import Moderna’s COVID-19 vaccine for emergency use

Covishield did not apply for approval, says EMA on leaving it out of its ‘Green Pass’

Covishield has been an important part of the international COVAX alliance, the vaccines with this initiative meed to have the WHO’s approval and on the other side, the Green Pass initiative was based on the EMA’s approval.

Serum Institute of India fulfils its commitment by producing over 10 crore Covishield doses in June

Government defends move to increase gap between two Covishield doses

Centre places order for 25 crore Covishield and 19 crore COVAXIN doses

The gap between two doses of Covishield can be extended to 12-16 weeks, says a government panel; no altercations to the interval of Covaxin

A government panel, on Thursday, has suggested that the interval between two doses of Covishield can be extended to 12-16 weeks. Well, this is the second time in three months that the interval has been extended.

COVID-19 situation in Punjab is expected to worsen: CM Amarinder expresses concern

Punjab CM Amarinder Singh in a meeting on Monday said that while stringent measures are being taken to tackle the surge in cases, he is not "proposing" a lockdown in the state.

Covishield to be available in govt hospitals at Rs 400, while in private hospitals at Rs 600

Around 50 per cent of the doses produced by vaccine makers will be provided “in the open market”.

COVID-19: Canada reports second case of blood clot from AstraZeneca jab

A second case has emerged of a person in Canada suffering from blood clots after taking AstraZeneca's COVID-19 vaccine jab, Canadian authorities continue to recommend the jab for those above 55 years of age.

‘Vaccine Maitri’ scheme is important for international cooperation: EAM Jaishankar

"International cooperation is not a one-way street- where we give to others and short change ourselves, I think people need to understand that," said EAM.

Testing positive for COVID-19 despite taking the vaccine? Everything you need to know!

Despite having received both the doses of the vaccine, many contracted Covid-19. But, still encourage people to get jab; Here’s why.

AAP questions Centre for supplying Covid-19 vaccines abroad

AAP said that the government is more concerned about Prime Minister Narendra Modi’s global image than saving people’s lives.